The Zhitong Finance App learned that Keji Pharmaceutical-B (02171.HK) rose by more than 6%. As of press release, it had risen 5.94% to HK$16.42, with a turnover of HK$32.628,500.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.